1. The Evolving Landscape of PAD Screening
Peripheral arterial disease (PAD) affects nearly 20 million U.S. adults, yet fewer than half are diagnosed before symptoms such as claudication appear.¹ Most clinics still depend on:
- Handheld Doppler ABI – guideline-recommended but time-intensive and operator-dependent.
- Automated single-cuff devices – faster, but limited to a surrogate ABI ratio and subject to payer scrutiny.
Recent studies reveal sensitivity gaps in diabetic or calcified vessels and workflow bottlenecks that suppress case-finding. In response, HealthWright Technologies Inc engineered the CMAT Advantage to unite ABI, pulse-volume recording (PVR), autonomic nervous system (ANS) metrics, and sudomotor analysis in a single 15-minute session—without adding staffing burden.
2. Side-by-Side Comparison
| Feature | CMAT Advantage | Handheld Doppler ABI | Automated Single-Cuff (e.g., QuantaFlo) |
| Tests per session | ABI + PVR + ANS (HRV) + sudomotor | ABI only | ABI surrogate pulse ratio |
| Time to result | 15 min | 12–20 min (operator-dependent) | 5 min |
| Staff skill required | MA after 90-min e-learning | RN/tech skilled with Doppler probe | MA |
| Medicare CPTs | 93922 · 95921 · 95923 (3 codes) | 93922 (1 code) | 93922 surrogate—higher audit risk |
| Sensitivity in diabetics | High—PVR offsets calcification | Lower (ABI alone) | Moderate |
| Workflow output | Color-coded PDF + EHR-ready XML | Numeric ratios, manual entry | App-based PDF |
| Avg. Note | Contact for details | N/A (minimal cap-ex) | Contact for details |
*Assumes 10 screens/week at 2025 Medicare national averages.
3. Clinical Evidence Highlights
- ABI limitations in diabetes – Manual ABI missed 29 % of angiography-proven PAD in a 2024 study of diabetic patients.²
- PVR accuracy boost – CMAT’s volume plethysmography preserved ≥ 92 % sensitivity regardless of vessel stiffness (2023 cohort).³
- Single-cuff scrutiny – Ongoing DOJ investigations into QuantaFlo marketing underscore payer concern over false-positive billing and up-coding.⁴
4. Coding Information
| Device | CPT Codes per Test | Avg. clinical value/Test* | Year-One Gross† | Typical Break-Even |
| CMAT Advantage | 93922 · 95921 · 95923 | Varies | ≈ Varies by payer | Contact for details |
| Handheld Doppler ABI | 93922 | Varies | Varies | Minimal cap-ex |
| Single-Cuff Device | 93922 surrogate | Varies‡ | Varies | Contact for details |
*Reimbursement rates vary by payer and region. Providers should verify coverage.
†Assumes 10 studies/week for 52 weeks.
‡Payment increasingly denied or down-coded by some payers.
5. Workflow & Training Considerations
- Rapid onboarding – Five-step e-learning (~ 90 min) certifies MAs as Certified CMAT Providers.
- Seamless EHR integration – XML/HL7 export eliminates transcription errors and speeds chart closure.
- Quality assurance – Quarterly business reviews surface clinical utilization and device performance and push software updates through the secure CMAT update portal.
6. When a Traditional Device Still Makes Sense
| Practice Scenario | Best-Fit Tool |
| Solo clinic (< 100 high-risk visits/year) with tight budgets | Handheld Doppler |
| Mobile screening fairs needing rapid prevalence data | Single-cuff device |
| Multi-specialty clinic expanding cardio-metabolic services | CMAT Advantage |
7. Key Take-Aways for Physicians
- Broader diagnostic reach – Vascular and autonomic complications screened in one sitting.
- Broader diagnostic value – Three established diagnostic tests in a single session provide more comprehensive clinical data than single-parameter alternatives.
- Regulatory safety – Aligns with established CPT definitions, lowering audit risk tied to surrogate indices.
Superior patient experience – Painless cuffs and galvanic sensors improve comfort and throughput.
Further Reading
- From PAD Screening to ANS Analysis: The CMAT Triple-CPT clinical value Stack — See how the CMAT device goes beyond PAD screening to deliver ANS analysis and triple-CPT billing potential.
- The Business Case for Adding CMAT TM-Flow Testing to Independent Clinics — Understand the clinical value and reimbursement landscape for CMAT testing in independent practices.
- TM-Flow in Chronic Disease Management — Discover how the TM-Flow System supports chronic disease management workflows.
- Have questions about the CMAT Advantage? Get in touch with our team.
Ready to get started? Learn how HealthWright Advantage bundles the device, training, and ongoing support your practice needs — backed by a 90-day buyback guarantee.
